Pediatric heart transplantation: The past, the present, and the future

Jason W Greenberg1, Amalia Guzman-Gomez2, Spencer Hogue2

  • 1The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave, Cincinnati, Ohio, 45229..

Insights

Pediatric heart transplantation (HTx) has advanced significantly, with survival now measured in decades due to improved immunosuppression and care. Future innovations aim to further enhance outcomes for children needing heart transplants.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Transplantation Medicine

Background:

  • Heart transplantation (HTx) has evolved from early 20th-century origins to become a life-saving procedure for pediatric patients.
  • The first pediatric orthotopic heart transplant occurred in 1967 for a neonate with Ebstein anomaly.
  • Currently, around 500 pediatric HTx procedures are performed annually worldwide.

Purpose of the Study:

  • To review the historical progression and current status of pediatric heart transplantation.
  • To highlight key advancements contributing to improved patient survival and outcomes.
  • To discuss future directions and innovations in the field of pediatric HTx.

Main Methods:

  • Historical review of heart transplantation milestones.
  • Analysis of current pediatric heart transplant statistics.
  • Discussion of advancements in medical and surgical care, including immunosuppression and mechanical support.

Main Results:

  • Pediatric heart transplant survival has dramatically improved, with outcomes now measured in decades.
  • Significant reductions in waitlist mortality and post-transplant complications have been achieved.
  • Key factors include advances in immunosuppression, critical care, specialized transplant teams, and mechanical circulatory support.

Conclusions:

  • Pediatric heart transplantation has transitioned from experimental to a standard, highly successful therapy.
  • Ongoing research focuses on developing novel intracorporeal ventricular assist devices (VADs) for pediatric use.
  • Future advancements include expanding donor criteria and exploring xenotransplantation to address organ shortages.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
58
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
515
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30